newsfilter
← Latest News
GlobeNewswire·

ContraFect Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

YONKERS, N.Y., May 20, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX) (ContraFect), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides,